X4 Pharmaceuticals, Inc (XFOR) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US98420X2027
X4 Pharmaceuticals, Inc financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 6.50 m USD |
| Gross profit | 743,000.00 USD |
| Operating income | -86.88 m USD |
| EBIT | -74.86 m USD |
| Net income | -79.20 m USD |
| Diluted EPS – continuing operations | -1.87 USD |
Full history since 2015, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About X4 Pharmaceuticals, Inc
X4 Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system. It offers XOLREMDI, an orally small-molecule selective antagonist of chemokine receptor CXCR4, which is in phase 3 clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome. It has a license agreement with Abbisko Therapeutics Co Ltd. to manufacture and distribute XOLREMDI in mainland China, Taiwan, Hong Kong and Macau; Norgine to develop, manufacture, and commercialize mavorixafor in Europe, Australia, and New Zealand; and Genzyme Corporation for CXCR4 receptor to develop and commercialize products containing licensed compounds for all therapeutic, prophylactic and diagnostic uses. The company is headquartered in Boston, Massachusetts.
More stocks
- NOVAL PROPERTY REAL ESTATE INVE (NOVAL.AT)
- WEBRAY ORD A (SHH) EQSW Exp: (688651.SS)
- Villeroy & Boch (VIB3.DE)
- Benitec Biopharma Inc. (BNTC)
- Kogeneracja SA (KGN.WA)
- Shih Her Technologies (3551.TWO)
- Universal Vision Biotechnology Co Ltd (3218.TWO)
- Guangdong Jushen Logistics Co Ltd (001202.SZ)
- Hangzhou Gisway Information Technology Co. Ltd. A (301390.SZ)
- WhiteFiber, Inc. (WYFI)
- Selvaag Bolig ASA (SBO.OL)
- Chengdu Shengbang Seals Co.Ltd. (301233.SZ)
Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.